tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Laura Sutcliffe, 26 are a BUY (42.62%), 35 are a HOLD (57.38%).
Analyst Laura Sutcliffe, currently employed at UBS, carries an average stock price target met ratio of 43.23% that have a potential upside of 31.89% achieved within 591 days. Previously, Laura Sutcliffe worked at CITI.
Laura Sutcliffe’s has documented 121 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BMY, Bristol-Myers Squibb Company at 07-Jan-2026.
Analyst best performing recommendations are on RMD (RESMED).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 5/18/2020. The price target of $217.34 was fulfilled within 3 days with a profit of $5.27 (2.37%) receiving and performance score of 7.89.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 16-Oct-2020
$32
$-1.11 (-3.35%)
$28
2 months 5 days ago
(07-Nov-2025)
13/16 (81.25%)
$0.47 (1.49%)
39
Sell
Since 14-Feb-2025
$22
$-11.11 (-33.55%)
$31
10 months 29 days ago
(14-Feb-2025)
3/6 (50%)
$-3.44 (-13.52%)
376
Sell
Since 23-Jan-2025
$82.77
11 months 20 days ago
(23-Jan-2025)
2/7 (28.57%)
$-1.59 (-1.88%)
32
Sell
Since 23-Jan-2023
$49
11 months 20 days ago
(23-Jan-2025)
2/5 (40%)
$2.78 (6.01%)
49
Sell
Since 01-Apr-2024
$31
$-2.11 (-6.37%)
$44
1 years 9 months 11 days ago
(01-Apr-2024)
6/9 (66.67%)
$-1.48 (-4.56%)
14
Which stock is Laura Sutcliffe is most bullish on?
Which stock is Laura Sutcliffe is most reserved on?
What Year was the first public recommendation made by Laura Sutcliffe?
